C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
11/2006
11/30/2006	WO2006126938A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
11/30/2006	WO2006055625A3 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
11/30/2006	US20060270874 Styrylsulfonamides
11/30/2006	US20060270856 Process for preparation of sulfamide derivatives
11/30/2006	US20060270719 2-[(Cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-2-yl-benzyl)-amino]-N-hydroxy-acetamide; selective inhibitors of matrix-degrading metalloproteinases, especially MT1-MMP, MMP-2 and MMP-9; Osteoporosis; Antitumor, antiproliferative agents
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/30/2006	CA2609735A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1658265A4 4-(methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
11/29/2006	CN1869015A Preparation method of N-[(3-aminophenyl) sulfuryl] acetamide
11/29/2006	CN1869014A Method of preparing tamsulosin and its related aralkyl amine derivative
11/29/2006	CN1869013A Opticall activity N-propargyl sulfamide monomer and related polymer and its preparation method
11/28/2006	US7141674 Anti-inflammatory compounds
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	CA2239853C Indane dimer compounds and their pharmaceutical use
11/28/2006	CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/23/2006	WO2006123020A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264480 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264435 Novel compounds
11/23/2006	US20060264424 Arylsulfonamidobenzylic compounds
11/23/2006	US20060264416 Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease
11/23/2006	CA2609161A1 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4
11/22/2006	EP1723102A2 N-substituted benzene sulfonamides
11/22/2006	EP1722827A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1301475B1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1080070B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
11/22/2006	CN1865258A Ortho-substituted aryl amides for controlling invertebrate pests
11/21/2006	US7138547 Antitumoral compounds
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006	US7138418 Pentafluorobenzenesulfonamides and analogs
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf
11/16/2006	WO2006083924A8 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
11/16/2006	WO2006081997A3 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostate hyperplasia, prostate carcinoma, and spinobulbar muscular atrophy
11/16/2006	US20060258884 4-(Methyl sulfonyl amino) phenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical compositions comprising the same
11/16/2006	US20060258742 Hydroxy tetrahydro-naphthalenylurea derivatives
11/16/2006	US20060258730 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
11/16/2006	US20060258728 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060257613 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/16/2006	CA2598365A1 Analogs of 4-hydroxyisoleucine and uses thereof
11/15/2006	EP1720830A1 Process for manufacturing optically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzene sulfonamide
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006	CN1863767A 2-cyanobenzenesulfonamides for combating animal pests
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135487 Sulphonamide derivatives
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006118283A1 Novel guanidine compound, method for producing same, and bactericidal composition using same
11/09/2006	WO2006117662A2 Polymorphic forms of (r)-(-)-tamsulosin
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	US20060252813 Apparatus for curing a composite laminate
11/09/2006	CA2599411A1 Enzyme inhibitors
11/08/2006	EP1324979B1 Ionic liquids and their use as solvents
11/08/2006	EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
11/08/2006	CN1859904A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
11/08/2006	CN1858038A Oxo fluoroalkyl sulfamide compound and its preparing method and use
11/08/2006	CN1283622C Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
11/08/2006	CN1283612C Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132546 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
11/07/2006	US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	CA2158268C N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
11/07/2006	CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006	WO2006114190A1 Novel specific caspase-10 inhibitors
11/02/2006	WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247460 Less toxic and less bioaccumulative than longer chain perfluorinated groups; for polymerizable water- and oil-repellent acrylic resins
11/02/2006	US20060247297 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1628953A4 Process for preparing reverse transcriptase inhibitors
11/02/2006	EP1419126B1 Fluorous nucleophilic substitution of alcohols and reagents for use therein
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	CA2605748A1 Novel specific caspase-10 inhibitors
11/01/2006	CN1856461A Cycloalkylidene compounds as modulators of estrogen receptor
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006	CN1282642C Intermediates for preparing aminophenylsulfonylureas and preparation method therefor
11/01/2006	CN1282641C Novel naphthylsulfonic acids and related compounds as glucose uptake agonists
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
10/2006
10/31/2006	US7129378 Method of preparing amine stereoisomers
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/26/2006	WO2003006628A3 Nad synthetase inhibitors and uses thereof
10/26/2006	US20060241155 TNF-alpha production inhibitors
10/26/2006	US20060241153 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
10/26/2006	US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
10/26/2006	US20060239915 Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases

1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 177